Editorial
Resveratrol inhibition of varicella-zoster virus replication in vitro
DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice
Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes
Antiviral activity of Arthrospira -derived spirulan-like substances
Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen
Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication
Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): Targeting Vpr and its cellular partner, the glucocorticoid receptor (GR)
StpC-based gene therapy targeting latent reservoirs of HIV-1
Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells
Antiviral activity of substituted homoisoflavonoids on enteroviruses
Erratum to “Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses” [Antiviral Res. 71 (2006) 322–334],